Azole resistance is becoming increasingly serious due to the frequent recurrence of fungal infections and the need for long-term clinical prevention. In our previous study, we discovered with an unknown function by TMT quantitative proteomics technology after fluconazole (FLC) treatment of . In this study, we created the target gene deletion strain using CRISPR-Cas9 editing technology to see if regulates azole sensitivity. The data showed that was involved in hyphal development and susceptibility to antifungal azoles. Deleting this gene resulted in defective hyphal growth in solid medium, while only a weak lag in the initiation of hyphal development and restoring hyphal growth during the hyphal maintenance phase under liquid conditions. Moreover, intracellular reactive oxygen species (ROS) assay and propidium iodide staining assays showed increased endogenous ROS levels and membrane permeability, but decreased metabolic activity of biofilm in after treatment with FLC in comparison with either SC5314 or strains. More importantly, significantly enhanced the FLC efficacy against in infected larvae. The above characteristics were fully or partially restored in the complemented strain indicating that the changes caused by deletion were specific. In summary, the gene is required for hyphal development of , and is correlated with the response to antifungal azoles and . The identification of is promising to expand the potential candidate targets for azoles.